NICE Talks

NICE has recommended teplizumab for NHS use — the first treatment to delay the onset of symptomatic type 1 diabetes by an average of nearly three years. In this episode, we speak to Lucy Chambers, Head of Research Impact and Communications at Diabetes UK, and Amy Norman, whose daughter Imogen accessed teplizumab through a managed access programme after being identified through the ELSA screening s...

In this episode we discuss the recent changes to the NICE guideline for neonatal infections, that mean newborn babies receiving antibiotics in hospital could potentially switch to oral antibiotics and be cared for at home, if they are doing well and responding to treatment. Guests: • Dr Tim Watts, guideline committee member and Consultant Neonatologist at the Evelina • Dr Harriet Aughey, Neonatal...

In this episode of NICE Talks, we're covering some of the most significant guidance updates of the year so far for women's health and cancer care. For the first time, NICE's updated fertility guideline includes a dedicated pathway specifically for people with endometriosis who are trying to conceive — a direct result of patient and clinician voices being heard during public consultation. We then t...

When the right technology reaches the right patient, lives change. In this episode of NICE Talks, we hear directly from people whose lives have been transformed by NICE-recommended healthtech, including a hybrid closed loop system for type 1 diabetes, an implantable cardiac monitor to detect atrial fibrillation following a stroke, and a rapid genetic test that protects newborns from hearing loss c...

In this episode, we discuss two innovative migraine treatments recommended by NICE. We explore the rapid uptake across the NHS with our three guests. We're joined by Joanne McShane, an NHS health visitor who suffered from migraine for a decade; Dr Kay Kennis, GP with an extended role in Headache at Bradford Community Neurology Service; and Rob Music, chief executive at The Migraine Trust.

In this episode of NICE Talks, we learn the impact of the joint asthma guideline published in November 2024. Developed collaboratively by the British Thoracic Society, NICE and the Scottish Intercollegiate Guidelines Network, the guideline has transformed how asthma is diagnosed and treated across the UK. We hear from frontline clinicians putting the guidance into practice and from those who helpe...

We look back on the guidance we've produced in 2025. We're joined by director of medicines evaluation Helen Knight, the deputy director of the centre for guidelines Eric Power, and Anastasia Chalkidou, the programme director of guidance delivery in HealthTech.

We're joined by representatives from the MHRA to discuss how NHS patients will be able to access medicines up to 6 months faster through an aligned MHRA and NICE pathway. Watch the webinar here: https://www.youtube.com/watch?v=FVBVYTUc2Q4

In this episode we learn how NICE is helping to deliver the government's 10 year health plan. Our guests are the senior responsible officers looking after the three NICE projects. They are: associate director for planning and operations Jenna Dilkes; deputy director for HealthTech Sarah Byron; anddeputy director for medicines evaluation Jac Bouvy.

In this episode, we discuss recent analysis showing significant disparities in SGLT-2 inhibitor prescriptions for people with type 2 diabetes in England. We also explore how our new draft recommendations for these medications could increase uptake with our three guests. They are: Dr Waqaar Shah, chair of the type 2 diabetes guideline committee; Dr Soon Song, consultant physician and diabetologist...

Our Health Technology Assessment Innovation Laboratory (HTA Lab) was launched in June 2023 to test and develop creative solutions to complex problems in health technology assessment. Joining us to discuss its first 2 years of success are our guests: Jamie Elvidge, senior scientific adviser at NICE; Jack Turner, deputy director for medicines access at NHS England; and Victoria Jordan, director of v...

NICE's prioritisation board has been in operation for just over 12 months. In this episode we review the first year and learn more about how decisions are made, incorporating the role of the patient voice. Our guests are Kay Nolan, head of prioritisation and surveillance at NICE, and Carole Pitkeathley, a lay member of NICE’s prioritisation board.

We're joined by health visitor Karen McLean and health psychologist Vivien Swanson, two members of the guideline committee, to discuss the changes made to the updated guideline to support nutrition and weight management in pregnancy, and nutrition in children up to 5 years. Find the guideline here: www.nice.org.uk/guidance/NG247

In this episode we’re going to be learning more about NICE's guidance for robotic assisted surgery. Our guests are Dr Anastasia Chalkidou, NICE’s HealthTech programme director. And John McGrath, consultant urologist at North Bristol NHS Trust, and chair of the NHSE Steering Committee for Robotic Assisted Surgery. Learn more about NICE's guidance for: Robotic-assisted surgery for soft tissue proced...

To mark endometriosis awareness month this March we discuss the global initiative, Endometriosis Explained, aiming to educate and support those affected by this condition. In this episode, we're joined by Emma Cox, CEO of Endometriosis UK and gynaecologist Christian Becker from the University of Oxford. Find our guideline here: https://www.nice.org.uk/guidance/ng73 And our quality standard here: h...

In this episode we’re going to be learning about how NICE is preparing to use artificial intelligence. Dr Pall Jonsson, programme director for data and real-world evidence at NICE and Dr Stephen Duffield, associate director for real-world evidence at NICE discuss the impact of this dynamic and rapidly advancing field. Find out more about NICE's work in AI and watch our recent webinar at: https://w...

In this episode we discuss our consultation on NICE's routing criteria for highly specialised technologies. Professor Jonathan Benger, our deputy chief executive and chief medical officer, outlines the proposals. Visit the consultation page to have your say: https://www.nice.org.uk/guidance/indevelopment/GID-PMG10008/consultation/html-content The consultation is open from Thursday 19 December 2024...

In this episode we’re going to be learning about the updated NICE guideline on the identification and management of the menopause. Our guests are Marie Anne Ledingham, a Consultant Clinical Adviser at NICE and an NHS obstetrician and gynecologist. And Professor Martha Hickey, consultant in Gynaecology at the Royal Women’s Hospital, Victoria, Australia and topic advisor on the NICE guideline commit...

In this episode we’re going to be learning about the role of NICE's independent advisory committees. How they operate, who are the members and what flexibility they have in deciding what medicines should be made available to NHS patients in England. Our guests are NICE's director of medicines evaluation Helen Knight and Professor Steve O'Brien, one of our independent advisory committee chairman.

In this episode, we hear from Professor Jonathan Benger, NICE's deputy chief executive and interim director of our Centre for Guidelines. He's joined by Dr Bryony Kendall who is a GP and sits on NICE committees producing guidelines on women's health. They discuss the vital role of our independent advisory committees and how you can get involved. Find out more about joining a NICE committee: www.ni...

The National Institute for Health and Care Excellence has, for the first time, published a guideline on the identification and management of adrenal insufficiency, a rare condition which occurs when the adrenal glands do not produce enough essential hormones – particularly cortisol and aldosterone. We're joined by Dr Helen Simpson, a consultant endocrinologist at UCLH NHS Foundation Trust and Sall...

We're joined by Mark Chapman, director of NICE's HealthTech programme and Verena Stocker, director of Innovation, Research, Life Sciences and Strategy at NHS England to discuss the benefits and opportunities the proposed pathway will offer. Take part in the consultation: https://www.engage.england.nhs.uk/specialised-commissioning/building-an-integrated-rules-based-medtech-pathway/

In this episode, our guests reflect on 25 years of NICE, how the organisation has developed, the impact its had and how it will change to adapt to the challenges of the next 25 years. Guests: NICE CEO Dr Sam Roberts, Chief Medical Officer for England Professor Sir Chris Whitty, MHRA CEO Dame June Raine, Director of Value and Access at Association of British HealthTech Industries Luella Trickett, a...

Following the publication of our new guideline, ovarian cancer: identifying and managing familial and genetic risk, the latest episode of NICETalks focuses on genetic testing and how it can help to identify those most at risk of ovarian cancer. We talk to Ranjit Manchanda, professor of gynaecological oncology, Queen Mary University of London and Barts Health NHS Trust, Dr Judith Hayward, GP with s...

In this month's podcast, we speak with Jeanette Kusel, director of NICE Advice and Luella Trickett, director of value and access at the Association of British HealthTech Industries. They outline the benefits and opportunities NICE Advice can provide. Go to: https://www.nice.org.uk/about/what-we-do/life-sciences/nice-advice-service?utm_medium=podcast&utm_source=nicetalks&utm_campaign=january2024&ut...